Keywords: isis, reduces, viral, load, hep, patients, pharmaceuticals

ISIS 14803 reduces viral load in Hep C patients

Article | 21 June 2001

Print This

ISIS Pharmaceuticals has presented data at the American Associationfor the Study of Liver Diseases' Single Topic Conference on Hepatitis C ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in